Market Closed

BIIB
Biogen
$ 253.40
1.17%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Biogen News

Latest Biogen Stock News & BIIB Headlines

Biogen Inc. $BIIB Stock: Allspring Global Investments Holdings LLC Boosts Holdings
2 days ago | defenseworld.net
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer's Disease
2 days ago | globenewswire.com
Two Neighbors Will Start Leqembi, Listed at $28,270 a Year. One With Medigap Plan G Will Owe $0 in Coinsurance After the Part B Deductible, While the Other Will Owe 20% of Medicare-Approved Infusion Costs
4 days ago | 247wallst.com
Biogen Inc. $BIIB Stock: Alpha Family Trust Boosts Holdings
5 days ago | defenseworld.net
These Analysts Increase Their Forecasts On Biogen After Upbeat Q3 Results
17 days ago | benzinga.com
Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026
17 days ago | globenewswire.com
Biogen Q3 Earnings Call Highlights
17 days ago | marketbeat.com
Biogen Inc. (BIIB) Q3 2026 Earnings Call Transcript
17 days ago | seekingalpha.com
BIIB's Q3 Earnings Beat, New Drugs Aid Sales, '26 EPS View Tightened
17 days ago | zacks.com
Big Day for Econ Data, Hyperscaler Earnings
17 days ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BIIB
Biogen
$ 253.40
1.17%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago